Thursday, December 4, 2008
What's the Harm?
In addition to preventing toxins from being sweat out of the body, antiperspirants contain Aluminum Chlorohydrate, as an active ingredient. The suspicion of aluminum as one of the contributing factors to Alzheimer's started back in the 1950's. In more recent years it has also been related Breast Cancer. One of the ways that women may increase their risk is by the application of an antiperspirant right after shaving because shaving causes very tiny nicks in the skin that allow these chemicals an easy entrance into the body.
Landmark EchoCRT Trial Enrolls First European Patients
Landmark EchoCRT Trial Enrolls First European Patients
BIOTRONIK announced that the first European patients have been enrolled into the EchoCRT (Echocardiography guided Cardiac Resynchronization Therapy) trial by the team of physicians at Hospital ClÃnic in Barcelona, Spain, led by Professor Dr. Josep Brugada, Director of the Thorax Institute, Chairman of the Cardiology Department, EchoCRT Executive Committee Member and President of the European Heart Rhythm Association.
CT-Scan Vs. Invasive Angiography: Statement From The ESC
Recent media reports based on a new study published in the New England Journal of Medicine (27 November 2008 issue) have announced that "noninvasive CT scans cannot replace imaging of coronary artery blockages by conventional invasive angiography". In response, imaging specialist Professor Juhani Knuuti, spokesperson for the European Society of Cardiology and Past-Chair of the ESC Working Group on Nuclear Cardiology and Cardiac CT, emphasizes the following points.
Medtronic Launches Sprinter(R) Angioplasty Balloon Cathethers On Rapid Exchange
Expanding its angioplasty product portfolio, Medtronic, Inc. (NYSE: MDT), announced today the U.S. market launch of the Sprinter Legend (semicompliant) and the NC Sprinter (noncompliant) balloon dilatation catheters on a rapid exchange delivery system. Recently approved by the U.S.
Two Drug Blood Pressure Therapy Reduces Heart Attacks
While doctors are urged to start with a diuretic-based strategy to control patients' high blood pressure, an international blood pressure study shows a different single-pill drug combination is more effective at preventing heart-related events such as heart attacks and strokes. The findings challenge the way blood pressure is usually treated worldwide. The randomized study led by a University of Michigan Health System researcher compared two drug combinations.
Multi-Translated HeartScore Revises Its Approach To Risk Assessment In Young Patients
A new release of HeartScore® the interactive tool designed to predict and help manage the risk of heart attack and stroke in Europe created by the European Society of Cardiology (ESC) was launched on Tuesday 18 November 2008 at http://www.HeartScore.org. This revised version includes relative risk for younger patients, in addition to patient data history and progress monitoring.
Investigating Numbness, Pain Or Muscle Weakness? Guidelines Identify Best Tests For Neuropathy
New guidelines developed by the American Academy of Neurology find a combination of blood tests and other specialized assessments appear to be the most helpful tests for finding the cause of neuropathy. Also known as neuritis or distal symmetric polyneuropathy, this common nerve problem affects people of all ages. The guidelines are published in the December 3, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology.
ConjuChem's PC-DAC(TM):Exendin-4 Lowers Glucose And Weight In Phase II Diabetes Trials
ConjuChem Biotechnologies, Inc. (TSX:CJB) announced preliminary results today showing that its Type 2 diabetes product, PC-DAC(TM):Exendin-4, achieved statistically significant reductions in HbA1c and weight in its two Phase II clinical trials. Commenting on the clinical results, Mark Perrin, President and CEO stated, "We are extremely pleased with these results which have met our clinical objectives. Achieving a 1.
Deborah Heart & Lung Center Receives Top Honors For Outstanding Cardiovascular Outcomes
The highest designation given to hospitals by the Society of Thoracic Surgeons (STS), a three-star rating for quality of heart surgery, has been awarded to Deborah Heart and Lung Center in Browns Mills, N.J. Only ten percent of heart centers throughout the nation attain this level. "We are extremely proud of our entire cardiac team for demonstrating the hard work and dedication that warrants a three-star rating," said Lynn B. McGrath, M.D.
BIOTRONIK announced that the first European patients have been enrolled into the EchoCRT (Echocardiography guided Cardiac Resynchronization Therapy) trial by the team of physicians at Hospital ClÃnic in Barcelona, Spain, led by Professor Dr. Josep Brugada, Director of the Thorax Institute, Chairman of the Cardiology Department, EchoCRT Executive Committee Member and President of the European Heart Rhythm Association.
CT-Scan Vs. Invasive Angiography: Statement From The ESC
Recent media reports based on a new study published in the New England Journal of Medicine (27 November 2008 issue) have announced that "noninvasive CT scans cannot replace imaging of coronary artery blockages by conventional invasive angiography". In response, imaging specialist Professor Juhani Knuuti, spokesperson for the European Society of Cardiology and Past-Chair of the ESC Working Group on Nuclear Cardiology and Cardiac CT, emphasizes the following points.
Medtronic Launches Sprinter(R) Angioplasty Balloon Cathethers On Rapid Exchange
Expanding its angioplasty product portfolio, Medtronic, Inc. (NYSE: MDT), announced today the U.S. market launch of the Sprinter Legend (semicompliant) and the NC Sprinter (noncompliant) balloon dilatation catheters on a rapid exchange delivery system. Recently approved by the U.S.
Two Drug Blood Pressure Therapy Reduces Heart Attacks
While doctors are urged to start with a diuretic-based strategy to control patients' high blood pressure, an international blood pressure study shows a different single-pill drug combination is more effective at preventing heart-related events such as heart attacks and strokes. The findings challenge the way blood pressure is usually treated worldwide. The randomized study led by a University of Michigan Health System researcher compared two drug combinations.
Multi-Translated HeartScore Revises Its Approach To Risk Assessment In Young Patients
A new release of HeartScore® the interactive tool designed to predict and help manage the risk of heart attack and stroke in Europe created by the European Society of Cardiology (ESC) was launched on Tuesday 18 November 2008 at http://www.HeartScore.org. This revised version includes relative risk for younger patients, in addition to patient data history and progress monitoring.
Investigating Numbness, Pain Or Muscle Weakness? Guidelines Identify Best Tests For Neuropathy
New guidelines developed by the American Academy of Neurology find a combination of blood tests and other specialized assessments appear to be the most helpful tests for finding the cause of neuropathy. Also known as neuritis or distal symmetric polyneuropathy, this common nerve problem affects people of all ages. The guidelines are published in the December 3, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology.
ConjuChem's PC-DAC(TM):Exendin-4 Lowers Glucose And Weight In Phase II Diabetes Trials
ConjuChem Biotechnologies, Inc. (TSX:CJB) announced preliminary results today showing that its Type 2 diabetes product, PC-DAC(TM):Exendin-4, achieved statistically significant reductions in HbA1c and weight in its two Phase II clinical trials. Commenting on the clinical results, Mark Perrin, President and CEO stated, "We are extremely pleased with these results which have met our clinical objectives. Achieving a 1.
Deborah Heart & Lung Center Receives Top Honors For Outstanding Cardiovascular Outcomes
The highest designation given to hospitals by the Society of Thoracic Surgeons (STS), a three-star rating for quality of heart surgery, has been awarded to Deborah Heart and Lung Center in Browns Mills, N.J. Only ten percent of heart centers throughout the nation attain this level. "We are extremely proud of our entire cardiac team for demonstrating the hard work and dedication that warrants a three-star rating," said Lynn B. McGrath, M.D.
Subscribe to:
Posts (Atom)
